Cargando…
Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease
Amlexanox, a small molecule targeted therapy which has been used in the treatment of atopic conditions was previously but is not currently available in the United States. Amlexanox has also been legally utilized and administered in Japan as a treatment for asthma, a chronic pulmonary disease charact...
Autores principales: | Dosanjh, Amrita, Won, Cindy Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757066/ https://www.ncbi.nlm.nih.gov/pubmed/33380937 |
Ejemplares similares
-
Rescue of nonsense mutations by amlexanox in human cells
por: Gonzalez-Hilarion, Sara, et al.
Publicado: (2012) -
Effectiveness of Amlexanox and Adcortyl
for the treatment of recurrent aphthous ulcers
por: Abbasi, Farid, et al.
Publicado: (2016) -
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
por: Li, Mengfan, et al.
Publicado: (2022) -
Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
por: Catalan-Serra, Ignacio, et al.
Publicado: (2018) -
Expression and function of histamine and its receptors in atopic dermatitis
por: Albrecht, M., et al.
Publicado: (2015)